Intercell's therapeutic Hepatitis C T-cell vaccine (IC41) advances to next Phase II clinical trial
Initial results expected in mid 2007
28-Sep-2006 -
Intercell AG announced the start of a Phase II - proof of concept - clinical trial for its therapeutic Hepatitis C vaccine (IC41). In this Phase II clinical trial, chronic Hepatitis C patients who have not received a previous treatment will be vaccinated with Intercell's therapeutic Hepatitis C ...
clinical trials
Germany
hepatitis C
+5